Mark Kleiman, an important thinker on drug and criminal justice policy, died at 68 of complications from a kidney transplant.
New York Times
- As early as the 1980’s he said the costs of cannabis prohibition outweighed the benefits. Nonetheless he argued for a middle way between prohibition and full commercialization, which he feared would abuse its power.
- That was his argument in this paper for the Rand Corporation
- His consulting company, which served the Washington state government in 2013, is called Botec Analysis. It stands for Back of the envelope calculation.
